Optigrid 45 by is a Animal medication manufactured, distributed, or labeled by Huvepharma, Inc. Drug facts, warnings, and ingredients follow.
Indications for Use: Complete Type C Medicated Feeds: For increased rate of weight gain, improved feed efficiency
and increased carcass leanness in growing beef steers and heifers fed in confinement for slaughter during the last
28 to 42 days on feed. Not for use in cattle intended for breeding.
Type C Top-Dress Medicated Feeds: For increased rate of weight gain and improved feed efficiency in growing beef
steers and heifers fed in confinement for slaughter during the last 28 to 42 days on feed. Not for use in cattle
intended for breeding. Note: Increased carcass leanness is not an approved indication for use with Top-Dress
Feeding.
Approved Concentrations of Ractopamine Hydrochloride in Complete Type C Medicated Feeds
|
a Based on 90% Dry Matter Basis |
||
| Indications for Use | Concentration of Ractopamine Hydrochloride in Type C Medicated Feeda |
Ractopamine HCl (mg/hd/d) |
| Increased Rate of Weight Gain, and Improved Feed Efficiency | 8.2 to 24.6 g/ton (9 ppm to 27 ppm) | 70-430 |
| Increased Rate of Weight Gain, Improved Feed Efficiency, and Increased Carcass Leanness | 9.8 to 24.6 g/ton (11 ppm to 27 ppm) | 90-430 |
|
a NC = No Change, ↑ = Increased, ↓ = Decreased |
|||
|
b Steers Only |
|||
|
c Reduction indicates an improvement in USDA Yield Grade. |
|||
| Carcass Measurements | Effect of Ractopamine Hydrochloridea | ||
| 8.2 grams/ton (9 ppm) | 16.4 grams/ton (18 ppm) | 24.6 grams/ton (27 ppm) |
|
| Hot Carcass Weight, lbs | ↑ | ↑ | ↑ |
| Dressing Percentage, % | NC | ↑b | ↑b |
| Carcass Percent Fat, % | NC | ↓ | ↓ |
| 12th Rib Fat Thickness, in. | NC | NC | NC |
| Average Rib Eye Area, sq. in. | ↑ | ↑ | ↑ |
| USDA Yield Grade | NC | NC | ↓c |
| Marbling Score | NC | NC | NC |
| Rate of Carcass Lean Gain per Day | NC | ↑ | ↑ |
| Efficiency of Carcass Lean Gain per Day | NC | ↑ | ↑ |
Approved Concentrations of Ractopamine Hydrochloride in Type C Top-Dress Medicated Feeds
|
a Based on 90% Dry Matter Basis |
||
| Indications for Use | Concentration of Ractopamine HCl in Type C Top-Dress Medicated Feeda | Ractopamine HCl (mg/hd/d) |
| Increased Rate of Weight Gain and Improved Feed Efficiency |
100 to 800 g/ton in a minimum of 1 lb of Type C | 70-400 |
Mixing Directions for Complete Type C Medicated Feeds: Thoroughly mix Optigrid 45 Type A Medicated Article in a ton of appropriate
feed ingredients according to the table below to obtain the proper concentration in the Type B Medicated Feed (maximum 4,920 g/ton).
The following table gives examples of how some Type B Medicated Feed concentrations can be prepared:
|
a Optigrid 45 contains 45.4 g ractopamine hydrochloride per pound |
||
|
b Based on 90% Dry Matter Basis |
||
| Pounds of Optigrid 45 a
To Add Per Ton To Make a Type B Medicated Feed | Resulting Ractopamine HCl Concentration in Type B Medicated Feedb |
|
| grams/ton | grams/pound | |
| 32.8 | 500 | 0.25 |
| 36.1 | 1,640 | 0.82 |
| 72.2 | 3,280 | 1.64 |
| 108.3 | 4,920 | 2.46 |
Thoroughly mix Optigrid 45 Type A Medicated Article in a ton of complete cattle feed according to the table below to obtain the proper
concentration in the Type C Medicated Feed. Prepare an intermediate pre-blend of the premix prior to mixing in a complete feed.
Thoroughly mix the required amount in a convenient quantity of feed ingredients then add to the remaining feed ingredients to make one
ton of complete feed.
|
a Optigrid 45 contains 45.4 g ractopamine hydrochloride per pound |
|
|
b Based on 90% Dry Matter Basis |
|
| Pounds of Optigrid 45a Per Ton To Make a Type C Medicated Feed | Resulting Ractopamine HCl Concentration in Type C Medicated Feedb |
| 0.18 | 8.2 grams/ton (9 ppm) |
| 0.36 | 16.4 grams/ton (18 ppm) |
| 0.54 | 24.6 grams/ton (27 ppm) |
Mixing Directions for Type B Liquid Medicated Feeds: Thoroughly mix Optigrid 45 Type A Medicated Article in a ton of appropriate feed
ingredients according to the table below to obtain the proper concentration in the Type B Medicated Feed (maximum 2,300 g/ton).
Maintain supplement pH at 4.5 to 7.5. For stored liquid Type B Medicated Feeds containing ractopamine, recirculate immediately prior
to use for not less than 10 minutes, moving not less than 1% of the tank contents per minute from the bottom of the tank to the top.
Recirculate daily as described even when not in use.
The following table gives examples of how some Type B Medicated Feed concentrations can be prepared:
|
a Optigrid 45 contains 45.4 g ractopamine hydrochloride per pound |
||
|
Pounds of Optigrid 45 a To Add Per Ton To Make a | Resulting Ractopamine HCl Concentration in Type B Liquid Medicated Feed |
|
| grams/ton | grams/pound | |
| 36.1 | 1,640 | 0.82 |
| 44.1 | 2,000 | 1 |
| 50.7 | 2,300 | 1.15 |
Mixing Directions for Type C Top-Dress Medicated Feeds: Thoroughly mix Optigrid 45 Type A Medicated Article in a ton of appropriate feed
ingredients according to the table below to obtain the proper concentration in the Type C Top-Dress Medicated Feed (100 to 800 g/ton).
The following table gives examples of how some Type C Top-Dress Medicated Feed concentrations can be prepared:
| aOptigrid 45 contains 45.4 g ractopamine hydrochloride per pound | |||
| bBased on 90% Dry Matter Basis | |||
| Pounds of Optigrid 45a To Add Per Ton To Make Type C Top-Dress Medicated Feed | Resulting Ractopamine HCl Concentration in Type C Top-Dress Medicated Feedb |
||
| Top-Dress | grams/ton | grams/pound | mg/pound |
| 2.2 | 100 | 0.05 | 50 |
| 4.41 | 200 | 0.1 | 100 |
| 6.61 | 300 | 0.15 | 150 |
| 8.81 | 400 | 0.2 | 200 |
| 17.62 | 800 | 0.4 | 400 |
Feeding Directions Complete Type C Medicated Feed: Feed as the sole ration during the last 28 to 42 days on feed.
Type C Top-Dress Medicated Feed: Feed a minimum of 1 lb per head per day of Type C top-dress medicated feed
containing 100 to 800 g/ton of ractopamine hydrochloride to provide 70 to 400 mg ractopamine hydrochloride
per head per day during the last 28 to 42 days on feed.
User Safety Warnings: Not for use in humans. Keep out of reach of children. The active ingredient in Optigrid, ractopamine hydrochloride,
is a beta-adrenergic agonist. Individuals with cardiovascular disease should exercise special caution to avoid exposure. The Optigrid
Type A medicated article poses a low dust potential under usual conditions of handling and mixing. When mixing and handling Optigrid, use
protective clothing, impervious gloves, protective eye wear, and a NIOSH-approved dust mask. Operators should wash thoroughly with soap and
water after handling. If accidental eye contact occurs, immediately rinse eyes thoroughly with water. If irritation persists, seek medical
attention. To obtain a Safety Data Sheet(s), contact Huvepharma, Inc. at 1-877-994-4883.
Animal Safety Warnings: Behavioral signs such as agitation and decreased feed consumption have been reported in cattle fed ractopamine
hydrochloride.
Additional Recommendations: See the Beef Quality Assurance (BQA) recommendations for best practices in cattle care and handling during
Optigrid feeding, transport, and marketing to help mitigate the behavioral signs stated in the Animal Safety Warnings section above.
Storage and Handling: Store at less than or equal to 25°C (77°F). Excursions to 40°C (104°F) are acceptable. Avoid excessive moisture.
Expiration Date and Lot Number are printed on the bag.
Not to be used after the expiry date.
Questions/Comments? For technical assistance or to report side effects, contact Huvepharma, Inc. at 1-877-994-4883 or www.huvepharma.com. For additional information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or www.fda.gov/reportanimalae
Restricted Drug (California) - Use Only as Directed
Approved by FDA under ANADA # 200-679

Optigrid® 45
Manufactured for: Huvepharma, Inc.
525 Westpark Dr., Ste 230
Peachtree City, GA 30269, U.S.A.
HUVEPHARMA and Optigrid 45 are trademarks of HUVEPHARMA EOOD.
Made in Bulgaria
| OPTIGRID 45
ractopamine hydrochloride powder |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
| Labeler - Huvepharma, Inc (619153559) |